Filing Details
- Accession Number:
- 0001209191-10-058872
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2010-12-07 16:52:06
- Reporting Period:
- 2010-12-03
- Filing Date:
- 2010-12-07
- Accepted Time:
- 2010-12-07 16:52:06
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1100962 | Endo Pharmaceuticals Holdings Inc | ENDP | Pharmaceutical Preparations (2834) | 134022871 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1328288 | P. Ivan Gergel | C/O Endo Pharmaceuticals 100 Endo Boulevard Chadds Ford PA 19317 | Evp, Research & Development | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock, Par Value, $.01 Per Share | Acquisiton | 2010-12-03 | 25,000 | $25.02 | 25,000 | No | 4 | M | Direct | |
| Common Stock, Par Value, $.01 Per Share | Acquisiton | 2010-12-03 | 30,603 | $19.93 | 55,603 | No | 4 | M | Direct | |
| Common Stock, Par Value, $.01 Per Share | Disposition | 2010-12-03 | 25,000 | $36.53 | 30,603 | No | 4 | S | Direct | |
| Common Stock, Par Value, $.01 Per Share | Disposition | 2010-12-03 | 30,603 | $36.53 | 0 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | 2004 Stock Incentive Plan Stock Options (NQ) | Disposition | 2010-12-03 | 25,000 | $0.00 | 25,000 | $25.02 |
| Common Stock | 2007 Stock Incentive Plan Stock Options (NQ) | Disposition | 2010-12-03 | 30,603 | $0.00 | 30,603 | $19.93 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 25,000 | 2018-04-29 | No | 4 | M | Direct | |
| 91,809 | 2019-02-26 | No | 4 | M | Direct |
Footnotes
- This represents the average price at which Dr. Gergel's common shares were sold at on December 3, 2010.
- Dr. Gergel's 50,000 non-qualified stock options granted under the 2004 Stock Incentive Plan on April 29, 2008, are generally exercisable 25% per year on each of April 29, 2009, April 29, 2010, April 29, 2011 and April 29, 2012.
- Dr. Gergel's 122,412 non-qualified stock options granted under the 2007 Stock Incentive Plan on February 26, 2009, are generally exercisable 25% per year on each of February 26, 2010, February 26, 2011, February 26, 2012 and February 26, 2013.
Billionaire Hedge Funds
